Cardiovascular symptoms in patients with systemic mast cell activation disease (Q38699417)

5 September 2017

title

Cardiovascular symptoms in patients with systemic mast cell activation disease (English)

1 reference

5 September 2017

0 references

Ulrich W Kolck

1

1 reference

5 September 2017

Britta Haenisch

series ordinal

2

1 reference

5 September 2017

Gerhard J Molderings

series ordinal

3

1 reference

5 September 2017

publication date

28 December 2015

1 reference

5 September 2017

published in

Translational Research

1 reference

5 September 2017

volume

174

1 reference

5 September 2017

page(s)

23-32.e1

1 reference

Mast cell: an emerging partner in immune interaction

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Biological implications of preformed mast cell mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Renin: at the heart of the mast cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Increased adventitial mast cells in a patient with coronary spasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Immunological characterization and functional importance of human heart mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells: a unique source of renin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Interaction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

5. IgE, mast cells, basophils, and eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells in the rat heart during normal growth and in cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells and vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells in human health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Cardiac mast cells: the centrepiece in adverse myocardial remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells play a critical role in the pathogenesis of viral myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Myocardial remodeling in diabetic cardiomyopathy associated with cardiac mast cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells in ongoing acute rejection: increase in number and expression of a different phenotype in rat heart transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Evidence for a role of mast cells in the evolution to congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

A role for cardiac mast cells in the pathogenesis of hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Takotsubo cardiomyopathy, mental stress and the Kounis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Tako-Tsubo-like syndrome during anaphylactic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Role of mast cell chymase and tryptase in the progression of atherosclerosis: study in 44 autopsied cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cells as effectors in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Histamine induces tissue factor expression: implications for acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Serum tryptase levels in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cell tryptase: a new biomarker in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cell chymase and tryptase in abdominal aortic aneurysm formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cell activation syndrome: Proposed diagnostic criteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

The genetic basis of mast cell activation disease - looking through a glass darkly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Pro-apoptotic Bax is the major and Bak an auxiliary effector in cytokine deprivation-induced mast cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Diagnostic criteria and classification of mastocytosis: a consensus proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Case-control cohort study of patients' perceptions of disability in mastocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Epidemiology of systemic mastocytosis in Denmark.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Prevalence of indolent systemic mastocytosis in a Dutch region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Familial occurrence of systemic mast cell activation disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Systemic mastocytosis associated with recurrent paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Shortness of breath, syncope, and cardiac arrest caused by systemic mastocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mastocytosis presenting as cardiac emergency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Facilitatory presynaptic angiotensin receptors on the sympathetic nerves of the human saphenous vein and pulmonary artery. Potential involvement in beta-adrenoceptor-mediated facilitation of noradrenaline release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Functional identification of histamine H3-receptors in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Therapeutic potential of H(3)-receptor agonists in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Effects of intravenous infusions of prostaglandin D2 in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Ivabradine in patients with inappropriate sinus tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Regulation of mast cells by beta-agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Unexplained loss of consciousness: systemic mastocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Survey of aspirin administration in systemic mastocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Omalizumab monotherapy for bee sting and unprovoked "anaphylaxis" in a patient with systemic mastocytosis and undetectable specific IgE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Biochemical diagnosis of systemic mast cell disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Systemic mast cell disease associated with the hypereosinophilic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

[Association of bone marrow mastocytosis with extremely immature extramedullary mast cell sarcoma]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Cardiac mast cells: implications for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Recommendations for the evaluation of left ventricular diastolic function by echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Correlation between mast cell density and myocardial fibrosis in congestive heart failure patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Kounis syndrome (allergic acute coronary syndrome): different views in allergologic and cardiologic literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

Mast-cell degranulation in human hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.12.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2015.12.012

1 reference

5 September 2017

1 reference